NCT02582385View on ClinicalTrials.gov

In-situ Cytokines Expression in the CNS in Amyotrophic Lateral Sclerosis (ALS)

CompletedOBSERVATIONAL
Enrollment

5

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

February 28, 2015

Study Completion Date

February 28, 2015

Conditions
Amyotrophic Lateral Sclerosis
Interventions
OTHER

in-situ cytokine expression

Trial Locations (1)

1020

CHU Brugmann, Brussels

All Listed Sponsors
lead

Brugmann University Hospital

OTHER

NCT02582385 - In-situ Cytokines Expression in the CNS in Amyotrophic Lateral Sclerosis (ALS) | Biotech Hunter | Biotech Hunter